Reduction of epileptiform activity in ketogenic mice: The role of monocarboxylate transporters
Abstract Epilepsy is a chronic neurological disorder that affects approximately 50 million people worldwide. Ketogenic diet (KD) can be a very effective treatment for intractable epilepsy. Potential mechanisms of action for KD have been proposed, including the re-balance among excitatory and inhibit...
Guardado en:
Autores principales: | Linda S. Forero-Quintero, Joachim W. Deitmer, Holger M. Becker |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3316e60dc7a3415fb0f81630a930ad78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cooperative transport mechanism of human monocarboxylate transporter 2
por: Bo Zhang, et al.
Publicado: (2020) -
Ketogenic diet improves core symptoms of autism in BTBR mice.
por: David N Ruskin, et al.
Publicado: (2013) -
The neuroplastin adhesion molecules are accessory proteins that chaperone the monocarboxylate transporter MCT2 to the neuronal cell surface.
por: Marieangela C Wilson, et al.
Publicado: (2013) -
Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression
por: Dillon M. Voss, et al.
Publicado: (2017) -
Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management
por: Goswami JN, et al.
Publicado: (2019)